undifferential myeloproliferative disorder (UMPD)

用法例句

Objective:To explore the dependability between the aging variation of expression of peroxisome proliferator-activated receptorγ(PPARγ)and core binding factora1(Cbfa1)and aging fracture healing impairment, we studied the expression of PPARγand Cbfa1 in aging fracture healing.

目的:通过对氧化物酶体增殖物激活受体γ(peroxisomeproliferator-activated receptorγ,PPARγ)以及核结合因子α1(core binding factorα1,Cbfα1)在增龄性骨折愈合过程中的表达情况,探讨PPARγ与Cbfα1基因的增龄性表达变化与增龄性骨折愈合障碍的联系。

Clinical Analysis of 104 Case of Nonleukemic Myeloproliferative Disorders;

非白血病性骨髓增生性疾病104例临床分析

JAK2V617F Point Mutation in Hematological Malignancies;

慢性骨髓增生性疾病JAK2基因V617F点突变研究

Study on JAK2 V617F point mutation in 141 patients with chronic myeloproliferatives diseases

141例慢性骨髓增生性疾病中JAK2基因V617F点突变的研究

Analysis of clinical and biological characteristics of myeloplastic and myeloproliferative disorders in children

儿童骨髓增生异常/骨髓增殖性疾病临床及生物学特征分析

Discussion of MD/MPD by the way of deficiency of the vital essestial and blood stasis

从正虚瘀结论治骨髓增生异常/骨髓增殖性疾病初探

Clinical Analysis of 126 Cases of Myeloproliferative Disease

骨髓增殖性疾病126例临床病例分析

Such massive splenomegaly is usually indicative of some myeloproliferative disease such as chronic myelogenous leukemia or myelofibrosis.

这样的脾肿大通常预示有骨髓增生型疾病，例如慢性髓性白血病或骨髓纤维化。

The Study of Tyrosine Kinase JAK2V617F Mutation in Human Myeloproliferative Disorders;

骨髓增殖性疾病JAK2V617F点突变研究

Advance of Study on JAK2 V617F in Myeloproliferative Disorders--Review

骨髓增殖性疾病JAK2 V617F研究进展

Study on Expression of JAK2 Mutation in Patients with Chronic Myeloproliferative Diseases and Its Targeted Therapy in Vitro;

慢性骨髓增殖性疾病JAK2基因突变发生情况及其靶向治疗的研究

Myelodysplastic syndrome( MDS) is a clonal disorder of the hematopoietic stem cell.

骨髓增生异常综合征是一种造血干细胞克隆异常性疾病。

Clinical Investigation of Myelodysplastic Syndrome with Autoimmune Disease;

骨髓增生异常综合征伴自身免疫性疾病的临床研究

Thrombelastograph examination in patients with chronic myeloproliferative disease

慢性骨髓增殖性疾病患者TEG检测的变化

The Expressions and Clinical Significance of JAK2V617F Mutation in the Patients with Myeloproliferative Disorders;

JAK2V617F突变在骨髓增殖性疾病中的表达及临床研究

A Study on the Correlation between JAK2V617F Mutation and the Expression Level of Cytokine Receptors in Myeloproliferative Disorders;

骨髓增殖性疾病中JAK2V617F突变与细胞因子受体表达的相关性研究

Clinic Study on Expression of JAK2 and MPL Mutations in Patients with Chronic Myeloproliferative Diseases;

慢性骨髓增殖性疾病JAK2及MPL基因突变的临床研究

Identification of an JAK2 Mutation in Chronic Myeloproliferative Disorders by dFARMS;

dFARMS检测慢性骨髓增殖性疾病JAK2基因的V617F点突变的研究

The Study of Tyrosine Kinase JAK2V617F Mutation in Human Myeloproliferative Disorders of Qinghai Province

蛋白激酶JAK2V617F点突变在青海省骨髓增殖性疾病中表达的相关性研究